Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of 5-HT receptor antagonists on cisplatin-induced kidney injury.
Goda M, Kanda M, Yoshioka T, Yoshida A, Murai Y, Zamami Y, Aizawa F, Niimura T, Hamano H, Okada N, Yagi K, Chuma M, Izawa-Ishizawa Y, Ishizawa K. Goda M, et al. Among authors: aizawa f. Clin Transl Sci. 2021 Sep;14(5):1906-1916. doi: 10.1111/cts.13045. Epub 2021 Jun 2. Clin Transl Sci. 2021. PMID: 33982438 Free PMC article.
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study.
Okada N, Izumi Y, Nakamoto A, Chuma M, Goda M, Yagi K, Aizawa F, Hamano H, Zamami Y, Azuma M, Ishizawa K. Okada N, et al. Among authors: aizawa f. Clin Ther. 2021 Nov;43(11):1910-1920.e3. doi: 10.1016/j.clinthera.2021.09.007. Epub 2021 Oct 9. Clin Ther. 2021. PMID: 34642081
Drug-Repositioning Approaches Based on Medical and Life Science Databases.
Zamami Y, Hamano H, Niimura T, Aizawa F, Yagi K, Goda M, Izawa-Ishizawa Y, Ishizawa K. Zamami Y, et al. Among authors: aizawa f. Front Pharmacol. 2021 Nov 1;12:752174. doi: 10.3389/fphar.2021.752174. eCollection 2021. Front Pharmacol. 2021. PMID: 34790124 Free PMC article. Review.
Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data.
Zamami Y, Niimura T, Kawashiri T, Goda M, Naito Y, Fukushima K, Ushio S, Aizawa F, Hamano H, Okada N, Yagi K, Miyata K, Takechi K, Chuma M, Koyama T, Kobayashi D, Shimazoe T, Fujino H, Izawa-Ishizawa Y, Ishizawa K. Zamami Y, et al. Among authors: aizawa f. Biomed Pharmacother. 2022 Apr;148:112744. doi: 10.1016/j.biopha.2022.112744. Epub 2022 Feb 28. Biomed Pharmacother. 2022. PMID: 35240525 Free article.
Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study.
Sakurada T, Nokihara H, Koga T, Zamami Y, Goda M, Yagi K, Hamano H, Aizawa F, Ogino H, Sato S, Kirino Y, Goto H, Nishioka Y, Ishizawa K. Sakurada T, et al. Among authors: aizawa f. Oncologist. 2022 Jul 5;27(7):e554-e560. doi: 10.1093/oncolo/oyab077. Oncologist. 2022. PMID: 35325241 Free PMC article. Clinical Trial.
Discovery of preventive drugs for cisplatin-induced acute kidney injury using big data analysis.
Kanda M, Goda M, Maegawa A, Yoshioka T, Yoshida A, Miyata K, Aizawa F, Niimura T, Hamano H, Okada N, Sakurada T, Chuma M, Yagi K, Izawa-Ishizawa Y, Yanagawa H, Zamami Y, Ishizawa K. Kanda M, et al. Among authors: aizawa f. Clin Transl Sci. 2022 Jul;15(7):1664-1675. doi: 10.1111/cts.13282. Epub 2022 Apr 30. Clin Transl Sci. 2022. PMID: 35445533 Free PMC article.
A web-based survey of educational opportunities of medical professionals based on changes in conference design during the COVID-19 pandemic.
Yagi K, Sato Y, Sakaguchi S, Goda M, Hamano H, Aizawa F, Shimizu M, Inoue-Hamano A, Nishimori T, Tagi M, Kanno M, Matsuoka-Ando R, Yoshioka T, Matstubara Y, Izawa-Ishizawa Y, Shimizu R, Maruo A, Kuniki Y, Sakamoto Y, Itobayashi S, Zamami Y, Yanagawa H, Ishizawa K. Yagi K, et al. Among authors: aizawa f. Educ Inf Technol (Dordr). 2022;27(7):10371-10386. doi: 10.1007/s10639-022-11032-5. Epub 2022 Apr 18. Educ Inf Technol (Dordr). 2022. PMID: 35464114 Free PMC article.
Investigation of drugs for the prevention of doxorubicin-induced cardiac events using big data analysis.
Nishiuchi S, Yagi K, Saito H, Zamami Y, Niimura T, Miyata K, Sakamoto Y, Fukunaga K, Ishida S, Hamano H, Aizawa F, Goda M, Chuma M, Izawa-Ishizawa Y, Nawa H, Yanagawa H, Kanda Y, Ishizawa K. Nishiuchi S, et al. Among authors: aizawa f. Eur J Pharmacol. 2022 Aug 5;928:175083. doi: 10.1016/j.ejphar.2022.175083. Epub 2022 May 31. Eur J Pharmacol. 2022. PMID: 35659512 Free article.
69 results